• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC® in the Press, November 5, 2021

Article

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A blog post by PhRMA referenced a study published in the October 2021 issue of The American Journal of Managed Care® (AJMC®). The study, “340B Drug Pricing Program and Hospital Provision of Uncompensated Care,” found that participation in the 340B Drug Pricing Program by general acute care hospitals and critical access hospitals has not been associated with increased provision of uncompensated care.

A piece by Oil City News cited an article published on AJMC.com, the website of AJMC®. The article, “A Timeline of COVID-19 Developments in 2020,” reviewed how the pandemic evolved and progressed through 2020, which closed with the arrival of vaccines but also continued challenges.

Related Videos
Eric Levin, Scripta
Margaret Krackeler, MD
Margaret Krackeler, MD
Margaret Krackeler, MD
Jennifer Snow, MPA, NAMI
Most employees are unprepared to shop for coverage on their own, underscoring the need for stronger decision tools and consumer protections.
Experts warn that ICHRAs could either stabilize or destabilize the individual market, depending on which workers employers shift into these plans.
Aleata Postell, SVP of pharmacy business development, CenterWell Pharmacy
Where patients live may shape outcomes in hypertrophic cardiomyopathy, with SDOH linked to higher risks of heart failure and arrhythmias.
Dr Marco Del Riccio
Related Content
© 2026 MJH Life Sciences
AJMC®
All rights reserved.